💊 Pharmaceuticals — Top Stocks by Market Cap
1,859 companies · updated every 5–20 min
| # | Name | Price | 24h % | 7d % | Market Cap | Volume (24h) | Last 7 Days |
|---|---|---|---|---|---|---|---|
| 401 | £2286.00 | -1.04% | +6.26% | £1.48B $1.88B · €1.69B | 178.77K shrs £408.68M | ||
| 402 | ¥12.21 | -2.55% | +1.88% | ¥13.64B $1.88B · €1.68B | 11.17M shrs ¥136.42M | ||
| 403 | $21.24 | -0.65% | +5.00% | $1.88B €1.68B | 2.08M shrs $44.11M | ||
| 404 | ₹795.15 | +1.52% | +5.98% | ₹156.3B $1.88B · €1.68B | 4.5K shrs ₹3.58M | ||
| 405 | ₹794.85 | +1.54% | +6.19% | ₹156.24B $1.87B · €1.68B | 63.49K shrs ₹50.47M | ||
| 406 | $28.76 | -0.03% | +38.58% | $1.87B €1.68B | 373.02K shrs $10.73M | ||
| 407 | €23.40 | -1.89% | -0.21% | €1.72B $1.87B | 139.34K shrs €3.26M | ||
| 408 | $13.23 | -0.68% | +13.05% | $1.85B €1.66B | 4.69M shrs $62M | ||
| 409 | ¥7.99 | +1.01% | +2.77% | ¥13.35B $1.84B · €1.65B | 8.69M shrs ¥69.45M | ||
| 410 | ₹1105.20 | +0.89% | -1.00% | ₹153.33B $1.84B · €1.65B | 437.28K shrs ₹483.28M | ||
| 411 | ₹1104.90 | +0.66% | +0.80% | ₹153.29B $1.84B · €1.65B | 91.83K shrs ₹101.46M | ||
| 412 | ¥109.56 | +7.94% | +8.21% | ¥13.33B $1.84B · €1.65B | 3.98M shrs ¥436.14M | ||
| 413 | ₩32550.00 | +1.72% | +2.89% | ₩2.55T $1.84B · €1.65B | 18.72K shrs ₩609.27M | ||
| 414 | ¥9.08 | -1.41% | +0.00% | ¥13.32B $1.84B · €1.65B | 2M shrs ¥18.2M | ||
| 415 | ¥5.29 | -2.94% | -3.13% | ¥13.32B $1.84B · €1.65B | 163.44M shrs ¥864.61M | ||
| 416 |  Tsumura & Co. 4540.T🇯🇵JPY | ¥3680.00 | -0.86% | -1.66% | ¥274.33B $1.84B · €1.65B | 187.5K shrs ¥690M | |
| 417 | ¥30.00 | +0.44% | -12.88% | ¥13.07B $1.80B · €1.62B | 3.06M shrs ¥91.89M | ||
| 418 | ₹946.00 | +0.22% | +0.35% | ₹149.85B $1.80B · €1.61B | 45.16K shrs ₹42.72M | ||
| 419 | ₹942.40 | -0.31% | +1.67% | ₹149.28B $1.79B · €1.60B | 3.13K shrs ₹2.95M | ||
| 420 | ¥8.02 | +0.38% | +1.53% | ¥12.96B $1.79B · €1.60B | 1.85M shrs ¥14.82M | ||
| 421 | ¥14.77 | -1.86% | +4.93% | ¥12.93B $1.78B · €1.60B | 4.71M shrs ¥69.52M | ||
| 422 | $31.93 | +0.63% | +12.87% | $1.77B €1.59B | 417.91K shrs $13.34M | ||
| 423 |  uniQure N.V. QURE🇺🇸USD | $25.30 | +1.32% | -7.89% | $1.75B €1.57B | 1.71M shrs $43.35M | |
| 424 | $4.89 | -1.01% | -3.24% | $1.74B €1.56B | 373.2K shrs $1.82M | ||
| 425 | ¥27.99 | -1.16% | +11.60% | ¥12.64B $1.74B · €1.56B | 1.7M shrs ¥47.69M | ||
| 426 | ₹787.55 | -0.69% | +3.73% | ₹144.91B $1.74B · €1.56B | 227.52K shrs ₹179.19M | ||
| 427 | $13.41 | -0.07% | -2.57% | $1.74B €1.56B | 1.04M shrs $13.91M | ||
| 428 | HK$6.89 | +0.51% | +4.59% | HK$13.58B $1.74B · €1.56B | 162K shrs HK$1.12M | ||
| 429 |  Novavax, Inc. NVAX🇺🇸USD | $10.47 | +1.45% | +5.11% | $1.73B €1.55B | 2.79M shrs $29.2M | |
| 430 |  Nanobiotix S.A. NBTX🇺🇸USD | $33.80 | -0.53% | +7.87% | $1.72B €1.54B | 85.57K shrs $2.89M | |
| 431 | ¥22.00 | +10.00% | -0.25% | ¥12.48B $1.72B · €1.54B | 16.67M shrs ¥366.67M | ||
| 432 | ₹315.35 | +3.33% | +1.08% | ₹142.91B $1.71B · €1.54B | 2.01M shrs ₹633.43M | ||
| 433 | ₹315.10 | +3.24% | — | ₹142.9B $1.71B · €1.54B | 99.1K shrs ₹31.23M | ||
| 434 | $26.35 | -0.23% | +5.14% | $1.7B €1.52B | 1.29M shrs $34.04M | ||
| 435 | kr 49.10 | -0.30% | +0.42% | kr 17.52B $1.70B · €1.52B | 13.57K shrs kr 666.53K | ||
| 436 | ₹787.75 | -0.71% | — | ₹141.09B $1.69B · €1.52B | 24.8K shrs ₹19.54M | ||
| 437 | HK$11.18 | -1.41% | +11.06% | HK$13.22B $1.69B · €1.52B | 1.11M shrs HK$12.39M | ||
| 438 | €30.32 | -0.13% | +6.88% | €1.54B $1.68B | 178.74K shrs €5.42M | ||
| 439 | $73.16 | +2.02% | +0.13% | $1.68B €1.50B | 262.4K shrs $19.2M | ||
| 440 | ¥72.43 | -0.85% | +20.95% | ¥12.17B $1.68B · €1.50B | 687.66K shrs ¥49.81M | ||
| 441 | $4.77 | +3.92% | -10.26% | $1.67B €1.50B | 6.5M shrs $30.99M | ||
| 442 | A$20.32 | +0.89% | +31.78% | A$2.58B $1.67B · €1.50B | 99.78K shrs A$2.03M | ||
| 443 | HK$15.46 | +2.11% | -1.56% | HK$12.95B $1.66B · €1.48B | 305.9K shrs HK$4.73M | ||
| 444 | $16.78 | -2.44% | +12.59% | $1.65B €1.48B | 2.8M shrs $47.02M | ||
| 445 | $17.39 | +8.28% | -1.75% | $1.65B €1.48B | 5.14M shrs $89.37M | ||
| 446 | $33.48 | -0.80% | +7.94% | $1.64B €1.47B | 1.42M shrs $47.69M | ||
| 447 | HK$76.20 | -0.26% | +9.95% | HK$12.77B $1.63B · €1.46B | 10.4K shrs HK$792.48K | ||
| 448 | ₹2215.05 | +0.78% | +6.11% | ₹135.47B $1.63B · €1.46B | 2.36K shrs ₹5.23M | ||
| 449 | €4.78 | +0.74% | -2.26% | €1.49B $1.62B | 197.89K shrs €944.94K | ||
| 450 | ₩61000.00 | -4.70% | -6.36% | ₩2.25T $1.62B · €1.45B | 51.19K shrs ₩3.12B | ||
| 451 | $31.27 | -4.11% | +8.39% | $1.61B €1.44B | 1.29M shrs $40.25M | ||
| 452 | $7.31 | +0.27% | -6.38% | $1.61B €1.44B | 2.21M shrs $16.15M | ||
| 453 | Fr 43.40 | -0.69% | +22.00% | Fr 1.43B $1.60B · €1.44B | 8.31K shrs Fr 360.57K | ||
| 454 | ¥21.36 | -2.69% | +15.03% | ¥11.61B $1.60B · €1.43B | 5.64M shrs ¥120.39M | ||
| 455 | ¥35.93 | +0.62% | +1.40% | ¥11.58B $1.60B · €1.43B | 488.5K shrs ¥17.55M | ||
| 456 | ¥82.10 | -4.81% | +11.75% | ¥11.57B $1.60B · €1.43B | 813.64K shrs ¥66.8M | ||
| 457 | ¥14.70 | +1.38% | +1.25% | ¥11.5B $1.59B · €1.42B | 1.72M shrs ¥25.29M | ||
| 458 | NT$38.85 | -4.79% | +8.76% | NT$50.93B $1.58B · €1.41B | 956.46K shrs NT$37.16M | ||
| 459 | $38.86 | +2.59% | +5.14% | $1.58B €1.41B | 100.82K shrs $3.92M | ||
| 460 | ₩210000.00 | -5.62% | +18.39% | ₩2.18T $1.57B · €1.41B | 24.43K shrs ₩5.13B | ||
| 461 | ₩38900.00 | -5.11% | -1.82% | ₩2.18T $1.57B · €1.40B | 78.58K shrs ₩3.06B | ||
| 462 | $21.94 | +2.14% | +14.27% | $1.56B €1.40B | 929.35K shrs $20.39M | ||
| 463 | ¥14.86 | +2.55% | -4.89% | ¥11.28B $1.56B · €1.39B | 3.94M shrs ¥58.53M | ||
| 464 | ¥27.45 | -4.29% | +25.58% | ¥11.26B $1.55B · €1.39B | 2.65M shrs ¥72.65M | ||
| 465 | ₹1230.60 | -2.99% | -2.40% | ₹128.74B $1.54B · €1.38B | 174.66K shrs ₹214.93M | ||
| 466 | ₹1229.90 | -3.08% | -3.97% | ₹128.67B $1.54B · €1.38B | 13.96K shrs ₹17.17M | ||
| 467 | ¥3419.00 | +0.03% | +0.91% | ¥230.44B $1.54B · €1.38B | 60.2K shrs ¥205.82M | ||
| 468 | ¥21.32 | +0.57% | +8.12% | ¥11.16B $1.54B · €1.38B | 3.65M shrs ¥77.84M | ||
| 469 |  Innoviva, Inc. INVA🇺🇸USD | $21.31 | +0.90% | -7.01% | $1.54B €1.38B | 626.92K shrs $13.36M | |
| 470 | ¥9.14 | +0.44% | -2.20% | ¥11.12B $1.53B · €1.37B | 2.39M shrs ¥21.83M | ||
| 471 | $53.67 | +3.61% | +9.38% | $1.53B €1.37B | 368.96K shrs $19.8M | ||
| 472 | ₹1130.95 | +1.34% | +1.80% | ₹127.74B $1.53B · €1.37B | 47.4K shrs ₹53.61M | ||
| 473 | ¥7770.00 | +5.00% | +2.76% | ¥228.75B $1.53B · €1.37B | 1.67M shrs ¥12.97B | ||
| 474 | ₹1130.10 | +0.99% | +0.78% | ₹127.64B $1.53B · €1.37B | 1.05M shrs ₹1.19B | ||
| 475 | ¥21.46 | -2.10% | +8.90% | ¥11.09B $1.53B · €1.37B | 4.23M shrs ¥90.72M | ||
| 476 | ¥10.40 | -0.76% | +8.61% | ¥10.98B $1.52B · €1.36B | 110.85M shrs ¥1.15B | ||
| 477 | NT$381.50 | -2.68% | -3.64% | NT$48.67B $1.51B · €1.35B | 167.06K shrs NT$63.73M | ||
| 478 | ₩91700.00 | -4.97% | +13.29% | ₩2.09T $1.50B · €1.34B | 49.08K shrs ₩4.5B | ||
| 479 | ¥11.70 | -0.76% | +10.08% | ¥10.86B $1.50B · €1.34B | 1.95M shrs ¥22.79M | ||
| 480 | ¥8.08 | +0.25% | -1.91% | ¥10.84B $1.50B · €1.34B | 1.15M shrs ¥9.3M | ||
| 481 | ¥18.86 | +0.37% | -1.96% | ¥10.79B $1.49B · €1.33B | 403.8K shrs ¥7.62M | ||
| 482 | $21.48 | -1.24% | -2.16% | $1.48B €1.32B | 734.9K shrs $15.79M | ||
| 483 |  GH Research PLC GHRS🇺🇸USD | $21.50 | +3.81% | +11.90% | $1.48B €1.32B | 345.1K shrs $7.42M | |
| 484 | ¥4.18 | +0.24% | -4.53% | ¥10.62B $1.47B · €1.31B | 10.35M shrs ¥43.28M | ||
| 485 | ¥12.78 | +0.00% | +0.24% | ¥10.54B $1.45B · €1.30B | 1.63M shrs ¥20.81M | ||
| 486 |  AtaiBeckley Inc. ATAI🇺🇸USD | $3.95 | -12.22% | +19.02% | $1.45B €1.30B | 9.16M shrs $36.2M | |
| 487 |  AnaptysBio, Inc. ANAB🇺🇸USD | $48.64 | -3.68% | +10.10% | $1.45B €1.30B | 414.33K shrs $20.15M | |
| 488 | $36.39 | +0.00% | +6.47% | $1.45B €1.30B | 618.92K shrs $22.52M | ||
| 489 | ¥39.68 | +2.80% | +7.10% | ¥10.48B $1.45B · €1.29B | 3.37M shrs ¥133.79M | ||
| 490 | ¥24.17 | +0.50% | -3.93% | ¥10.42B $1.44B · €1.29B | 2.03M shrs ¥49.11M | ||
| 491 | $26.95 | +0.00% | — | $1.43B €1.28B | 1.8M shrs $48.54M | ||
| 492 | ¥76.95 | +0.44% | +27.79% | ¥10.34B $1.43B · €1.28B | 4.14M shrs ¥318.27M | ||
| 493 | ¥25.40 | -0.04% | -0.49% | ¥10.3B $1.42B · €1.27B | 688.48K shrs ¥17.49M | ||
| 494 | ¥43.94 | +2.91% | +10.70% | ¥10.27B $1.42B · €1.27B | 13.95M shrs ¥613.1M | ||
| 495 | ₩107100.00 | -7.04% | -9.14% | ₩1.97T $1.42B · €1.27B | 39.24K shrs ₩4.2B | ||
| 496 | ¥28.70 | +0.38% | +14.17% | ¥10.26B $1.42B · €1.27B | 1.74M shrs ¥49.81M | ||
| 497 | ¥10.60 | -0.09% | -0.67% | ¥10.19B $1.41B · €1.26B | 3.45M shrs ¥36.57M | ||
| 498 | $6.43 | +0.31% | +5.56% | $1.41B €1.26B | 12.54K shrs $80.65K | ||
| 499 | HK$139.50 | -1.07% | +6.38% | HK$10.98B $1.41B · €1.26B | 5K shrs HK$697.5K | ||
| 500 | $14.88 | -0.70% | +5.58% | $1.39B €1.24B | 11.23K shrs $167.07K |
Browse by Country
Europe
Asia